Comprehensive single-cell transcriptomic and proteomic analysis reveals NK cell exhaustion and unique tumor cell evolutionary trajectory in non-keratinizing nasopharyngeal carcinoma

Nonkeratinizing nasopharyngeal carcinoma (NK-NPC) has a strong association with Epstein-Barr virus (EBV) infection. The role of NK cells and the tumor cell evolutionary trajectory in NK-NPC remain unclear. In this study, we aim to investigate the function of NK cell and the evolutionary trajectory o...

Full description

Saved in:
Bibliographic Details
Published inJournal of translational medicine Vol. 21; no. 1; p. 278
Main Authors Chen, Cuimin, Wang, Chun, Pang, Ruifang, Liu, Huanyu, Yin, Weihua, Chen, Jiakang, Tao, Lili
Format Journal Article
LanguageEnglish
Published England BioMed Central Ltd 25.04.2023
BioMed Central
BMC
Subjects
Analysis
Antigens
Cancer cells
Cell interactions
Cell surface
Cells
Cloning
Clustering
Cytotoxicity
Diagnosis
EBV
Epstein-Barr virus
Epstein-Barr Virus Infections - complications
Evolution
Evolutionary trajectory
Gene expression
Genetic aspects
Head and Neck Neoplasms
Health aspects
Herpesvirus 4, Human - physiology
Humans
Hyperplasia
Immunohistochemistry
Immunology
Immunotherapy
Infections
Killer Cells, Natural - metabolism
Ligands
Metastases
Mucosa
Nasopharyngeal cancer
Nasopharyngeal carcinoma
Nasopharyngeal Carcinoma - genetics
Nasopharyngeal Neoplasms - genetics
Natural killer cells
NK cell exhaustion
NK-NPC
Peptides
Proteins
Proteomics
Quality control
single-cell RNA sequencing
Software
Squamous Cell Carcinoma of Head and Neck
Throat cancer
Transcriptome - genetics
Transcriptomics
Tumor cells
Tumors
China
United States > US
Massachusetts
single-cell RNA sequencing
EBV
NK-NPC
Evolutionary trajectory
NK cell exhaustion
Proteomics
Online AccessGet full text

Cover

Abstract Nonkeratinizing nasopharyngeal carcinoma (NK-NPC) has a strong association with Epstein-Barr virus (EBV) infection. The role of NK cells and the tumor cell evolutionary trajectory in NK-NPC remain unclear. In this study, we aim to investigate the function of NK cell and the evolutionary trajectory of tumor cells in NK-NPC by single-cell transcriptomic analysis, proteomics and immunohistochemistry. NK-NPC (n = 3) and normal nasopharyngeal mucosa cases (n = 3) were collected for proteomic analysis. Single-cell transcriptomic data of NK-NPC (n = 10) and nasopharyngeal lymphatic hyperplasia (NLH, n = 3) were obtained from Gene Expression Omnibus (GSE162025 and GSE150825). Quality control, dimension reduction and clustering were based on Seurat software (v4.0.2) process and batch effects were removed by harmony (v0.1.1) software. Normal cells of nasopharyngeal mucosa and tumor cells of NK-NPC were identified using copykat software (v1.0.8). Cell-cell interactions were explored using CellChat software (v1.4.0). Tumor cell evolutionary trajectory analysis was performed using SCORPIUS software (v1.0.8). Protein and gene function enrichment analyses were performed using clusterProfiler software (v4.2.2). A total of 161 differentially expressed proteins were obtained between NK-NPC (n = 3) and normal nasopharyngeal mucosa (n = 3) by proteomics (log fold change > 0.5 and P value < 0.05). Most of proteins associated with the nature killer cell mediated cytotoxicity pathway were downregulated in the NK-NPC group. In single cell transcriptomics, we identified three NK cell subsets (NK1-3), among which NK cell exhaustion was identified in the NK3 subset with high ZNF683 expression (a signature of tissue-resident NK cell) in NK-NPC. We demonstrated the presence of this ZNF683 + NK cell subset in NK-NPC but not in NLH. We also performed immunohistochemical experiments with TIGIT and LAG3 to confirm NK cell exhaustion in NK-NPC. Moreover, the trajectory analysis revealed that the evolutionary trajectory of NK-NPC tumor cells was associated with the status of EBV infection (active or latent). The analysis of cell-cell interactions uncovered a complex network of cellular interactions in NK-NPC. This study revealed that the NK cell exhaustion might be induced by upregulation of inhibitory receptors on the surface of NK cells in NK-NPC. Treatments for the reversal of NK cell exhaustion may be a promising strategy for NK-NPC. Meanwhile, we identified a unique evolutionary trajectory of tumor cells with active status of EBV-infection in NK-NPC for the first time. Our study may provide new immunotherapeutic targets and new sight of evolutionary trajectory involving tumor genesis, development and metastasis in NK-NPC.
AbstractList Background Nonkeratinizing nasopharyngeal carcinoma (NK-NPC) has a strong association with Epstein-Barr virus (EBV) infection. The role of NK cells and the tumor cell evolutionary trajectory in NK-NPC remain unclear. In this study, we aim to investigate the function of NK cell and the evolutionary trajectory of tumor cells in NK-NPC by single-cell transcriptomic analysis, proteomics and immunohistochemistry. Methods NK-NPC (n = 3) and normal nasopharyngeal mucosa cases (n = 3) were collected for proteomic analysis. Single-cell transcriptomic data of NK-NPC (n = 10) and nasopharyngeal lymphatic hyperplasia (NLH, n = 3) were obtained from Gene Expression Omnibus (GSE162025 and GSE150825). Quality control, dimension reduction and clustering were based on Seurat software (v4.0.2) process and batch effects were removed by harmony (v0.1.1) software. Normal cells of nasopharyngeal mucosa and tumor cells of NK-NPC were identified using copykat software (v1.0.8). Cell-cell interactions were explored using CellChat software (v1.4.0). Tumor cell evolutionary trajectory analysis was performed using SCORPIUS software (v1.0.8). Protein and gene function enrichment analyses were performed using clusterProfiler software (v4.2.2). Results A total of 161 differentially expressed proteins were obtained between NK-NPC (n = 3) and normal nasopharyngeal mucosa (n = 3) by proteomics (log.sub.2 fold change > 0.5 and P value < 0.05). Most of proteins associated with the nature killer cell mediated cytotoxicity pathway were downregulated in the NK-NPC group. In single cell transcriptomics, we identified three NK cell subsets (NK1-3), among which NK cell exhaustion was identified in the NK3 subset with high ZNF683 expression (a signature of tissue-resident NK cell) in NK-NPC. We demonstrated the presence of this ZNF683 + NK cell subset in NK-NPC but not in NLH. We also performed immunohistochemical experiments with TIGIT and LAG3 to confirm NK cell exhaustion in NK-NPC. Moreover, the trajectory analysis revealed that the evolutionary trajectory of NK-NPC tumor cells was associated with the status of EBV infection (active or latent). The analysis of cell-cell interactions uncovered a complex network of cellular interactions in NK-NPC. Conclusions This study revealed that the NK cell exhaustion might be induced by upregulation of inhibitory receptors on the surface of NK cells in NK-NPC. Treatments for the reversal of NK cell exhaustion may be a promising strategy for NK-NPC. Meanwhile, we identified a unique evolutionary trajectory of tumor cells with active status of EBV-infection in NK-NPC for the first time. Our study may provide new immunotherapeutic targets and new sight of evolutionary trajectory involving tumor genesis, development and metastasis in NK-NPC. Keywords: Proteomics, single-cell RNA sequencing, NK-NPC, NK cell exhaustion, EBV, Evolutionary trajectory
Abstract Background Nonkeratinizing nasopharyngeal carcinoma (NK-NPC) has a strong association with Epstein-Barr virus (EBV) infection. The role of NK cells and the tumor cell evolutionary trajectory in NK-NPC remain unclear. In this study, we aim to investigate the function of NK cell and the evolutionary trajectory of tumor cells in NK-NPC by single-cell transcriptomic analysis, proteomics and immunohistochemistry. Methods NK-NPC (n = 3) and normal nasopharyngeal mucosa cases (n = 3) were collected for proteomic analysis. Single-cell transcriptomic data of NK-NPC (n = 10) and nasopharyngeal lymphatic hyperplasia (NLH, n = 3) were obtained from Gene Expression Omnibus (GSE162025 and GSE150825). Quality control, dimension reduction and clustering were based on Seurat software (v4.0.2) process and batch effects were removed by harmony (v0.1.1) software. Normal cells of nasopharyngeal mucosa and tumor cells of NK-NPC were identified using copykat software (v1.0.8). Cell-cell interactions were explored using CellChat software (v1.4.0). Tumor cell evolutionary trajectory analysis was performed using SCORPIUS software (v1.0.8). Protein and gene function enrichment analyses were performed using clusterProfiler software (v4.2.2). Results A total of 161 differentially expressed proteins were obtained between NK-NPC (n = 3) and normal nasopharyngeal mucosa (n = 3) by proteomics (log2 fold change > 0.5 and P value < 0.05). Most of proteins associated with the nature killer cell mediated cytotoxicity pathway were downregulated in the NK-NPC group. In single cell transcriptomics, we identified three NK cell subsets (NK1-3), among which NK cell exhaustion was identified in the NK3 subset with high ZNF683 expression (a signature of tissue-resident NK cell) in NK-NPC. We demonstrated the presence of this ZNF683 + NK cell subset in NK-NPC but not in NLH. We also performed immunohistochemical experiments with TIGIT and LAG3 to confirm NK cell exhaustion in NK-NPC. Moreover, the trajectory analysis revealed that the evolutionary trajectory of NK-NPC tumor cells was associated with the status of EBV infection (active or latent). The analysis of cell-cell interactions uncovered a complex network of cellular interactions in NK-NPC. Conclusions This study revealed that the NK cell exhaustion might be induced by upregulation of inhibitory receptors on the surface of NK cells in NK-NPC. Treatments for the reversal of NK cell exhaustion may be a promising strategy for NK-NPC. Meanwhile, we identified a unique evolutionary trajectory of tumor cells with active status of EBV-infection in NK-NPC for the first time. Our study may provide new immunotherapeutic targets and new sight of evolutionary trajectory involving tumor genesis, development and metastasis in NK-NPC.
BACKGROUNDNonkeratinizing nasopharyngeal carcinoma (NK-NPC) has a strong association with Epstein-Barr virus (EBV) infection. The role of NK cells and the tumor cell evolutionary trajectory in NK-NPC remain unclear. In this study, we aim to investigate the function of NK cell and the evolutionary trajectory of tumor cells in NK-NPC by single-cell transcriptomic analysis, proteomics and immunohistochemistry. METHODSNK-NPC (n = 3) and normal nasopharyngeal mucosa cases (n = 3) were collected for proteomic analysis. Single-cell transcriptomic data of NK-NPC (n = 10) and nasopharyngeal lymphatic hyperplasia (NLH, n = 3) were obtained from Gene Expression Omnibus (GSE162025 and GSE150825). Quality control, dimension reduction and clustering were based on Seurat software (v4.0.2) process and batch effects were removed by harmony (v0.1.1) software. Normal cells of nasopharyngeal mucosa and tumor cells of NK-NPC were identified using copykat software (v1.0.8). Cell-cell interactions were explored using CellChat software (v1.4.0). Tumor cell evolutionary trajectory analysis was performed using SCORPIUS software (v1.0.8). Protein and gene function enrichment analyses were performed using clusterProfiler software (v4.2.2). RESULTSA total of 161 differentially expressed proteins were obtained between NK-NPC (n = 3) and normal nasopharyngeal mucosa (n = 3) by proteomics (log2 fold change > 0.5 and P value < 0.05). Most of proteins associated with the nature killer cell mediated cytotoxicity pathway were downregulated in the NK-NPC group. In single cell transcriptomics, we identified three NK cell subsets (NK1-3), among which NK cell exhaustion was identified in the NK3 subset with high ZNF683 expression (a signature of tissue-resident NK cell) in NK-NPC. We demonstrated the presence of this ZNF683 + NK cell subset in NK-NPC but not in NLH. We also performed immunohistochemical experiments with TIGIT and LAG3 to confirm NK cell exhaustion in NK-NPC. Moreover, the trajectory analysis revealed that the evolutionary trajectory of NK-NPC tumor cells was associated with the status of EBV infection (active or latent). The analysis of cell-cell interactions uncovered a complex network of cellular interactions in NK-NPC. CONCLUSIONSThis study revealed that the NK cell exhaustion might be induced by upregulation of inhibitory receptors on the surface of NK cells in NK-NPC. Treatments for the reversal of NK cell exhaustion may be a promising strategy for NK-NPC. Meanwhile, we identified a unique evolutionary trajectory of tumor cells with active status of EBV-infection in NK-NPC for the first time. Our study may provide new immunotherapeutic targets and new sight of evolutionary trajectory involving tumor genesis, development and metastasis in NK-NPC.
Abstract Background Nonkeratinizing nasopharyngeal carcinoma (NK-NPC) has a strong association with Epstein-Barr virus (EBV) infection. The role of NK cells and the tumor cell evolutionary trajectory in NK-NPC remain unclear. In this study, we aim to investigate the function of NK cell and the evolutionary trajectory of tumor cells in NK-NPC by single-cell transcriptomic analysis, proteomics and immunohistochemistry. Methods NK-NPC (n = 3) and normal nasopharyngeal mucosa cases (n = 3) were collected for proteomic analysis. Single-cell transcriptomic data of NK-NPC (n = 10) and nasopharyngeal lymphatic hyperplasia (NLH, n = 3) were obtained from Gene Expression Omnibus (GSE162025 and GSE150825). Quality control, dimension reduction and clustering were based on Seurat software (v4.0.2) process and batch effects were removed by harmony (v0.1.1) software. Normal cells of nasopharyngeal mucosa and tumor cells of NK-NPC were identified using copykat software (v1.0.8). Cell-cell interactions were explored using CellChat software (v1.4.0). Tumor cell evolutionary trajectory analysis was performed using SCORPIUS software (v1.0.8). Protein and gene function enrichment analyses were performed using clusterProfiler software (v4.2.2). Results A total of 161 differentially expressed proteins were obtained between NK-NPC (n = 3) and normal nasopharyngeal mucosa (n = 3) by proteomics (log 2 fold change > 0.5 and P value < 0.05). Most of proteins associated with the nature killer cell mediated cytotoxicity pathway were downregulated in the NK-NPC group. In single cell transcriptomics, we identified three NK cell subsets (NK1-3), among which NK cell exhaustion was identified in the NK3 subset with high ZNF683 expression (a signature of tissue-resident NK cell) in NK-NPC. We demonstrated the presence of this ZNF683 + NK cell subset in NK-NPC but not in NLH. We also performed immunohistochemical experiments with TIGIT and LAG3 to confirm NK cell exhaustion in NK-NPC. Moreover, the trajectory analysis revealed that the evolutionary trajectory of NK-NPC tumor cells was associated with the status of EBV infection (active or latent). The analysis of cell-cell interactions uncovered a complex network of cellular interactions in NK-NPC. Conclusions This study revealed that the NK cell exhaustion might be induced by upregulation of inhibitory receptors on the surface of NK cells in NK-NPC. Treatments for the reversal of NK cell exhaustion may be a promising strategy for NK-NPC. Meanwhile, we identified a unique evolutionary trajectory of tumor cells with active status of EBV-infection in NK-NPC for the first time. Our study may provide new immunotherapeutic targets and new sight of evolutionary trajectory involving tumor genesis, development and metastasis in NK-NPC.
Nonkeratinizing nasopharyngeal carcinoma (NK-NPC) has a strong association with Epstein-Barr virus (EBV) infection. The role of NK cells and the tumor cell evolutionary trajectory in NK-NPC remain unclear. In this study, we aim to investigate the function of NK cell and the evolutionary trajectory of tumor cells in NK-NPC by single-cell transcriptomic analysis, proteomics and immunohistochemistry. NK-NPC (n = 3) and normal nasopharyngeal mucosa cases (n = 3) were collected for proteomic analysis. Single-cell transcriptomic data of NK-NPC (n = 10) and nasopharyngeal lymphatic hyperplasia (NLH, n = 3) were obtained from Gene Expression Omnibus (GSE162025 and GSE150825). Quality control, dimension reduction and clustering were based on Seurat software (v4.0.2) process and batch effects were removed by harmony (v0.1.1) software. Normal cells of nasopharyngeal mucosa and tumor cells of NK-NPC were identified using copykat software (v1.0.8). Cell-cell interactions were explored using CellChat software (v1.4.0). Tumor cell evolutionary trajectory analysis was performed using SCORPIUS software (v1.0.8). Protein and gene function enrichment analyses were performed using clusterProfiler software (v4.2.2). A total of 161 differentially expressed proteins were obtained between NK-NPC (n = 3) and normal nasopharyngeal mucosa (n = 3) by proteomics (log fold change > 0.5 and P value < 0.05). Most of proteins associated with the nature killer cell mediated cytotoxicity pathway were downregulated in the NK-NPC group. In single cell transcriptomics, we identified three NK cell subsets (NK1-3), among which NK cell exhaustion was identified in the NK3 subset with high ZNF683 expression (a signature of tissue-resident NK cell) in NK-NPC. We demonstrated the presence of this ZNF683 + NK cell subset in NK-NPC but not in NLH. We also performed immunohistochemical experiments with TIGIT and LAG3 to confirm NK cell exhaustion in NK-NPC. Moreover, the trajectory analysis revealed that the evolutionary trajectory of NK-NPC tumor cells was associated with the status of EBV infection (active or latent). The analysis of cell-cell interactions uncovered a complex network of cellular interactions in NK-NPC. This study revealed that the NK cell exhaustion might be induced by upregulation of inhibitory receptors on the surface of NK cells in NK-NPC. Treatments for the reversal of NK cell exhaustion may be a promising strategy for NK-NPC. Meanwhile, we identified a unique evolutionary trajectory of tumor cells with active status of EBV-infection in NK-NPC for the first time. Our study may provide new immunotherapeutic targets and new sight of evolutionary trajectory involving tumor genesis, development and metastasis in NK-NPC.
Nonkeratinizing nasopharyngeal carcinoma (NK-NPC) has a strong association with Epstein-Barr virus (EBV) infection. The role of NK cells and the tumor cell evolutionary trajectory in NK-NPC remain unclear. In this study, we aim to investigate the function of NK cell and the evolutionary trajectory of tumor cells in NK-NPC by single-cell transcriptomic analysis, proteomics and immunohistochemistry. NK-NPC (n = 3) and normal nasopharyngeal mucosa cases (n = 3) were collected for proteomic analysis. Single-cell transcriptomic data of NK-NPC (n = 10) and nasopharyngeal lymphatic hyperplasia (NLH, n = 3) were obtained from Gene Expression Omnibus (GSE162025 and GSE150825). Quality control, dimension reduction and clustering were based on Seurat software (v4.0.2) process and batch effects were removed by harmony (v0.1.1) software. Normal cells of nasopharyngeal mucosa and tumor cells of NK-NPC were identified using copykat software (v1.0.8). Cell-cell interactions were explored using CellChat software (v1.4.0). Tumor cell evolutionary trajectory analysis was performed using SCORPIUS software (v1.0.8). Protein and gene function enrichment analyses were performed using clusterProfiler software (v4.2.2). A total of 161 differentially expressed proteins were obtained between NK-NPC (n = 3) and normal nasopharyngeal mucosa (n = 3) by proteomics (log.sub.2 fold change > 0.5 and P value < 0.05). Most of proteins associated with the nature killer cell mediated cytotoxicity pathway were downregulated in the NK-NPC group. In single cell transcriptomics, we identified three NK cell subsets (NK1-3), among which NK cell exhaustion was identified in the NK3 subset with high ZNF683 expression (a signature of tissue-resident NK cell) in NK-NPC. We demonstrated the presence of this ZNF683 + NK cell subset in NK-NPC but not in NLH. We also performed immunohistochemical experiments with TIGIT and LAG3 to confirm NK cell exhaustion in NK-NPC. Moreover, the trajectory analysis revealed that the evolutionary trajectory of NK-NPC tumor cells was associated with the status of EBV infection (active or latent). The analysis of cell-cell interactions uncovered a complex network of cellular interactions in NK-NPC. This study revealed that the NK cell exhaustion might be induced by upregulation of inhibitory receptors on the surface of NK cells in NK-NPC. Treatments for the reversal of NK cell exhaustion may be a promising strategy for NK-NPC. Meanwhile, we identified a unique evolutionary trajectory of tumor cells with active status of EBV-infection in NK-NPC for the first time. Our study may provide new immunotherapeutic targets and new sight of evolutionary trajectory involving tumor genesis, development and metastasis in NK-NPC.
ArticleNumber 278
Audience Academic
Author Yin, Weihua
Liu, Huanyu
Pang, Ruifang
Chen, Jiakang
Tao, Lili
Chen, Cuimin
Wang, Chun
Author_xml – sequence: 1
  givenname: Cuimin
  surname: Chen
  fullname: Chen, Cuimin
  organization: Department of Pathology, Peking University Shenzhen Hospital, Shenzhen, China
– sequence: 2
  givenname: Chun
  surname: Wang
  fullname: Wang, Chun
  organization: Department of Pathology, Peking University Shenzhen Hospital, Shenzhen, China
– sequence: 3
  givenname: Ruifang
  surname: Pang
  fullname: Pang, Ruifang
  organization: Department of Precision Research Institute, Peking University Shenzhen Hospital, Shenzhen, China
– sequence: 4
  givenname: Huanyu
  surname: Liu
  fullname: Liu, Huanyu
  organization: Department of Pathology, Peking University Shenzhen Hospital, Shenzhen, China
– sequence: 5
  givenname: Weihua
  surname: Yin
  fullname: Yin, Weihua
  organization: Department of Pathology, Peking University Shenzhen Hospital, Shenzhen, China
– sequence: 6
  givenname: Jiakang
  surname: Chen
  fullname: Chen, Jiakang
  email: 2228778160@qq.com
  organization: Department of Pathology, Peking University Shenzhen Hospital, Shenzhen, China. 2228778160@qq.com
– sequence: 7
  givenname: Lili
  orcidid: 0000-0003-4976-4266
  surname: Tao
  fullname: Tao, Lili
  email: 651055473@qq.com
  organization: Department of Pathology, Peking University Shenzhen Hospital, Shenzhen, China. 651055473@qq.com
BackLink https://www.ncbi.nlm.nih.gov/pubmed/37098551$$D View this record in MEDLINE/PubMed
BookMark eNptUsuO1DAQjNAi9gE_wAFZ4sIli534lRNajXisWMEFzpbjdDIeEjvYyWiX_-L_cGaG1QxCPtjurqp2t-syO3PeQZa9JPiaEMnfRlJUXOS4KHNMCSly-SS7IFRUOZOCnx2dz7PLGDcYF5TR6ll2XgpcScbIRfZ75YcxwBpctFtA0bquh9xA36MpaBdNsOPkB2uQdg0ag5_gcNP9Q7QRBdiC7iP68hntWHC_1nOcrHc7xuzszxnQNA8-HABb389LXoeHpcYGzOTT0TqU-st_QNCTdfZXeglyOvpxnYCuS0WQ0cFY5wf9PHvapqLw4rBfZd8_vP-2-pTfff14u7q5yw3jdMpLzrWQLafcCI0lli0xpGZFXdWtZsAEa9oKN6bRUFSYm7qtMTWslQXn6YrLq-x2r9t4vVFjsEN6i_Laql3Ah07pMFnTgypbIoyRAqBmtBFUUkwYM40hrGqAm6T1bq81zvUAjQGXmu9PRE8zzq5V57eKYFIIhnlSeHNQCD4NNU5qsHGZqXbg56gKiTllouAiQV__A934OaQ_W1CEcU4kPkJ1OnVgXetTYbOIqhtBBaZYVAvq-j-otBpITkiWbG2KnxCKPcEEH2OA9rFJgtXiXLV3rkrOVTvnKplIr47H80j5a9XyDyUt8KU
CitedBy_id crossref_primary_10_1016_j_intimp_2024_111696
crossref_primary_10_1186_s13578_024_01218_4
crossref_primary_10_18632_aging_205448
crossref_primary_10_1186_s40364_023_00502_8
crossref_primary_10_1016_j_heliyon_2024_e26091
crossref_primary_10_3390_cancers16071312
crossref_primary_10_1007_s12033_024_01065_1
crossref_primary_10_18632_aging_205927
Cites_doi 10.1038/s41590-018-0132-0
10.1002/ctm2.1065
10.1016/j.smim.2019.101305
10.1007/s00262-019-02336-6
10.1038/s41422-020-0374-x
10.1002/ijc.31279
10.1007/s00428-020-02815-7
10.1111/sji.13029
10.1182/blood-2008-02-142596
10.1038/s41423-018-0011-5
10.1128/JVI.01085-12
10.3389/fimmu.2019.01999
10.1038/nri3370
10.1016/j.canlet.2021.06.008
10.1038/s41467-019-11632-9
10.1038/s41590-022-01267-2
10.1016/S0140-6736(19)30956-0
10.1038/s41467-021-21043-4
10.1128/JVI.79.7.4415-4424.2005
10.1038/s41422-020-00402-8
10.3389/fimmu.2018.02821
10.1038/s41598-017-10386-y
ContentType Journal Article
Copyright 2023. The Author(s).
COPYRIGHT 2023 BioMed Central Ltd.
2023. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
The Author(s) 2023
Copyright_xml – notice: 2023. The Author(s).
– notice: COPYRIGHT 2023 BioMed Central Ltd.
– notice: 2023. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: The Author(s) 2023
DBID CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
3V.
7T5
7X7
7XB
88E
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BENPR
CCPQU
DWQXO
FYUFA
GHDGH
H94
K9.
M0S
M1P
PIMPY
PQEST
PQQKQ
PQUKI
PRINS
7X8
5PM
DOA
DOI 10.1186/s12967-023-04112-8
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
ProQuest Central (Corporate)
Immunology Abstracts
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central
ProQuest Central Essentials
ProQuest Central
ProQuest One Community College
ProQuest Central
Health Research Premium Collection
Health Research Premium Collection (Alumni)
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
Health & Medical Collection (Alumni Edition)
PML(ProQuest Medical Library)
Publicly Available Content Database
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
MEDLINE - Academic
PubMed Central (Full Participant titles)
Directory of Open Access Journals
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
Publicly Available Content Database
ProQuest Central Essentials
ProQuest One Academic Eastern Edition
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Central China
ProQuest Hospital Collection (Alumni)
ProQuest Central
ProQuest Health & Medical Complete
Health Research Premium Collection
ProQuest Medical Library
ProQuest One Academic UKI Edition
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
AIDS and Cancer Research Abstracts
Immunology Abstracts
ProQuest One Academic
ProQuest Medical Library (Alumni)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList

MEDLINE - Academic
Publicly Available Content Database
CrossRef
MEDLINE
Database_xml – sequence: 1
  dbid: DOA
  name: Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 4
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1479-5876
EndPage 278
ExternalDocumentID oai_doaj_org_article_3f17cc87eeb54d74840155cdc159de6c
A747040797
10_1186_s12967_023_04112_8
37098551
Genre Research Support, Non-U.S. Gov't
Journal Article
GeographicLocations China
United States--US
Massachusetts
GeographicLocations_xml – name: China
– name: United States--US
– name: Massachusetts
GrantInformation_xml – fundername: ;
  grantid: LCYJZD2021007
– fundername: ;
  grantid: JSGG20201102162802008
GroupedDBID ---
-A0
0R~
29L
2WC
3V.
53G
5VS
6PF
7X7
88E
8FI
8FJ
AAFWJ
AAJSJ
AAWTL
ABDBF
ABUWG
ACGFO
ACGFS
ACIHN
ACIWK
ACPRK
ACRMQ
ADBBV
ADINQ
ADUKV
AEAQA
AENEX
AFKRA
AFPKN
AFRAH
AHBYD
AHMBA
AHYZX
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AMKLP
AMTXH
AOIJS
BAPOH
BAWUL
BCNDV
BENPR
BFQNJ
BMC
BPHCQ
BVXVI
C24
C6C
CCPQU
CGR
CS3
CUY
CVF
DIK
DU5
E3Z
EBD
EBLON
EBS
ECM
EIF
ESX
F5P
FYUFA
GROUPED_DOAJ
GX1
HMCUK
HYE
IAO
IHR
INH
INR
ITC
KQ8
M1P
M48
M~E
NPM
O5R
O5S
OK1
P2P
PGMZT
PIMPY
PQQKQ
PROAC
PSQYO
RBZ
RNS
ROL
RPM
RSV
SBL
SOJ
TR2
TUS
UKHRP
WOQ
WOW
XSB
~8M
AAYXX
CITATION
ABVAZ
AFGXO
AFNRJ
7T5
7XB
8FK
AZQEC
DWQXO
H94
K9.
PQEST
PQUKI
PRINS
7X8
5PM
ID FETCH-LOGICAL-c564t-366a78f646c7a0808f1c1b52b9bfa5e575df90dcdae2906cbfb04c5f826606c03
IEDL.DBID RPM
ISSN 1479-5876
IngestDate Tue Oct 22 15:08:04 EDT 2024
Tue Sep 17 21:30:53 EDT 2024
Sat Oct 05 06:02:30 EDT 2024
Thu Oct 10 18:10:14 EDT 2024
Thu Feb 22 23:49:16 EST 2024
Fri Feb 02 04:25:30 EST 2024
Thu Sep 12 18:07:07 EDT 2024
Sat Sep 28 08:18:07 EDT 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords single-cell RNA sequencing
EBV
NK-NPC
Evolutionary trajectory
NK cell exhaustion
Proteomics
Language English
License 2023. The Author(s).
Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c564t-366a78f646c7a0808f1c1b52b9bfa5e575df90dcdae2906cbfb04c5f826606c03
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ORCID 0000-0003-4976-4266
OpenAccessLink https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10127506/
PMID 37098551
PQID 2815661807
PQPubID 43076
PageCount 1
ParticipantIDs doaj_primary_oai_doaj_org_article_3f17cc87eeb54d74840155cdc159de6c
pubmedcentral_primary_oai_pubmedcentral_nih_gov_10127506
proquest_miscellaneous_2806457267
proquest_journals_2815661807
gale_infotracmisc_A747040797
gale_infotracacademiconefile_A747040797
crossref_primary_10_1186_s12967_023_04112_8
pubmed_primary_37098551
PublicationCentury 2000
PublicationDate 2023-04-25
PublicationDateYYYYMMDD 2023-04-25
PublicationDate_xml – month: 04
  year: 2023
  text: 2023-04-25
  day: 25
PublicationDecade 2020
PublicationPlace England
PublicationPlace_xml – name: England
– name: London
PublicationTitle Journal of translational medicine
PublicationTitleAlternate J Transl Med
PublicationYear 2023
Publisher BioMed Central Ltd
BioMed Central
BMC
Publisher_xml – name: BioMed Central Ltd
– name: BioMed Central
– name: BMC
References B Sanchez-Correa (4112_CR18) 2019; 68
YP Chen (4112_CR6) 2020; 30
E Ruffo (4112_CR17) 2019; 42
P Parham (4112_CR10) 2013; 13
L Tao (4112_CR13) 2020; 477
L Golden-Mason (4112_CR12) 2013; 87
J Bi (4112_CR15) 2019; 10
H Wang (4112_CR8) 2021; 517
XM Zhou (4112_CR19) 2018; 9
S Jin (4112_CR7) 2020; 30
ND Patil (4112_CR9) 2021; 94
A Christofides (4112_CR3) 2022; 23
Y Wang (4112_CR2) 2018; 142
W Zou (4112_CR5) 2018; 15
TC Chen (4112_CR21) 2017; 7
N Ahsan (4112_CR22) 2005; 79
X Li (4112_CR14) 2022; 12
Y Chen (4112_CR1) 2019; 394
N Marquardt (4112_CR11) 2019; 10
Q Zhang (4112_CR16) 2018; 19
J Klibi (4112_CR20) 2009; 113
Y Liu (4112_CR4) 2021; 12
References_xml – volume: 19
  start-page: 723
  issue: 7
  year: 2018
  ident: 4112_CR16
  publication-title: Nat Immunol
  doi: 10.1038/s41590-018-0132-0
  contributor:
    fullname: Q Zhang
– volume: 12
  issue: 10
  year: 2022
  ident: 4112_CR14
  publication-title: Clin Transl Med
  doi: 10.1002/ctm2.1065
  contributor:
    fullname: X Li
– volume: 42
  year: 2019
  ident: 4112_CR17
  publication-title: Semin Immunol
  doi: 10.1016/j.smim.2019.101305
  contributor:
    fullname: E Ruffo
– volume: 68
  start-page: 861
  issue: 5
  year: 2019
  ident: 4112_CR18
  publication-title: Cancer Immunol Immunother
  doi: 10.1007/s00262-019-02336-6
  contributor:
    fullname: B Sanchez-Correa
– volume: 30
  start-page: 1024
  issue: 11
  year: 2020
  ident: 4112_CR6
  publication-title: Cell Res
  doi: 10.1038/s41422-020-0374-x
  contributor:
    fullname: YP Chen
– volume: 142
  start-page: 2558
  issue: 12
  year: 2018
  ident: 4112_CR2
  publication-title: Int J Cancer
  doi: 10.1002/ijc.31279
  contributor:
    fullname: Y Wang
– volume: 477
  start-page: 573
  issue: 4
  year: 2020
  ident: 4112_CR13
  publication-title: Virchows Arch
  doi: 10.1007/s00428-020-02815-7
  contributor:
    fullname: L Tao
– volume: 94
  issue: 2
  year: 2021
  ident: 4112_CR9
  publication-title: Scand J Immunol
  doi: 10.1111/sji.13029
  contributor:
    fullname: ND Patil
– volume: 113
  start-page: 1957
  issue: 9
  year: 2009
  ident: 4112_CR20
  publication-title: Blood
  doi: 10.1182/blood-2008-02-142596
  contributor:
    fullname: J Klibi
– volume: 15
  start-page: 419
  issue: 5
  year: 2018
  ident: 4112_CR5
  publication-title: Cell Mol Immunol
  doi: 10.1038/s41423-018-0011-5
  contributor:
    fullname: W Zou
– volume: 87
  start-page: 4835
  issue: 9
  year: 2013
  ident: 4112_CR12
  publication-title: J Virol
  doi: 10.1128/JVI.01085-12
  contributor:
    fullname: L Golden-Mason
– volume: 10
  start-page: 1999
  year: 2019
  ident: 4112_CR15
  publication-title: Front Immunol
  doi: 10.3389/fimmu.2019.01999
  contributor:
    fullname: J Bi
– volume: 13
  start-page: 133
  issue: 2
  year: 2013
  ident: 4112_CR10
  publication-title: Nat Rev Immunol
  doi: 10.1038/nri3370
  contributor:
    fullname: P Parham
– volume: 517
  start-page: 96
  year: 2021
  ident: 4112_CR8
  publication-title: Cancer Lett
  doi: 10.1016/j.canlet.2021.06.008
  contributor:
    fullname: H Wang
– volume: 10
  start-page: 3841
  issue: 1
  year: 2019
  ident: 4112_CR11
  publication-title: Nat Commun
  doi: 10.1038/s41467-019-11632-9
  contributor:
    fullname: N Marquardt
– volume: 23
  start-page: 1148
  issue: 8
  year: 2022
  ident: 4112_CR3
  publication-title: Nat Immunol
  doi: 10.1038/s41590-022-01267-2
  contributor:
    fullname: A Christofides
– volume: 394
  start-page: 64
  issue: 10192
  year: 2019
  ident: 4112_CR1
  publication-title: Lancet
  doi: 10.1016/S0140-6736(19)30956-0
  contributor:
    fullname: Y Chen
– volume: 12
  start-page: 741
  issue: 1
  year: 2021
  ident: 4112_CR4
  publication-title: Nat Commun
  doi: 10.1038/s41467-021-21043-4
  contributor:
    fullname: Y Liu
– volume: 79
  start-page: 4415
  issue: 7
  year: 2005
  ident: 4112_CR22
  publication-title: J Virol
  doi: 10.1128/JVI.79.7.4415-4424.2005
  contributor:
    fullname: N Ahsan
– volume: 30
  start-page: 950
  issue: 11
  year: 2020
  ident: 4112_CR7
  publication-title: Cell Res
  doi: 10.1038/s41422-020-00402-8
  contributor:
    fullname: S Jin
– volume: 9
  start-page: 2821
  year: 2018
  ident: 4112_CR19
  publication-title: Front Immunol
  doi: 10.3389/fimmu.2018.02821
  contributor:
    fullname: XM Zhou
– volume: 7
  start-page: 10349
  issue: 1
  year: 2017
  ident: 4112_CR21
  publication-title: Sci Rep
  doi: 10.1038/s41598-017-10386-y
  contributor:
    fullname: TC Chen
SSID ssj0024549
Score 2.4614491
Snippet Nonkeratinizing nasopharyngeal carcinoma (NK-NPC) has a strong association with Epstein-Barr virus (EBV) infection. The role of NK cells and the tumor cell...
Abstract Background Nonkeratinizing nasopharyngeal carcinoma (NK-NPC) has a strong association with Epstein-Barr virus (EBV) infection. The role of NK cells...
Background Nonkeratinizing nasopharyngeal carcinoma (NK-NPC) has a strong association with Epstein-Barr virus (EBV) infection. The role of NK cells and the...
BackgroundNonkeratinizing nasopharyngeal carcinoma (NK-NPC) has a strong association with Epstein-Barr virus (EBV) infection. The role of NK cells and the...
BACKGROUNDNonkeratinizing nasopharyngeal carcinoma (NK-NPC) has a strong association with Epstein-Barr virus (EBV) infection. The role of NK cells and the...
Abstract Background Nonkeratinizing nasopharyngeal carcinoma (NK-NPC) has a strong association with Epstein-Barr virus (EBV) infection. The role of NK cells...
SourceID doaj
pubmedcentral
proquest
gale
crossref
pubmed
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
StartPage 278
SubjectTerms Analysis
Antigens
Cancer cells
Cell interactions
Cell surface
Cells
Cloning
Clustering
Cytotoxicity
Diagnosis
EBV
Epstein-Barr virus
Epstein-Barr Virus Infections - complications
Evolution
Evolutionary trajectory
Gene expression
Genetic aspects
Head and Neck Neoplasms
Health aspects
Herpesvirus 4, Human - physiology
Humans
Hyperplasia
Immunohistochemistry
Immunology
Immunotherapy
Infections
Killer Cells, Natural - metabolism
Ligands
Metastases
Mucosa
Nasopharyngeal cancer
Nasopharyngeal carcinoma
Nasopharyngeal Carcinoma - genetics
Nasopharyngeal Neoplasms - genetics
Natural killer cells
NK cell exhaustion
NK-NPC
Peptides
Proteins
Proteomics
Quality control
single-cell RNA sequencing
Software
Squamous Cell Carcinoma of Head and Neck
Throat cancer
Transcriptome - genetics
Transcriptomics
Tumor cells
Tumors
SummonAdditionalLinks – databaseName: Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1JixQxFA4yB_Ei7paOEkHwIGFSW5bjKA6D4pwcmFvIarc6aempFsf_5f_zvVR104UHLx6r8kJSeXvl5QshL2tfhy40DtIS7RhoImfWtp5xp0UKCWLoVApkz8Tpeff-or_Yu-oLa8JGeOBx4Y7aVEvvlYzR9V1A5Ev08j548MMhCl-sL9fbZGqLsgdpz_aIjBJHV-DVwCCAf2K8gwiDqZkbKmj9f9vkPac0L5jc80And8jtKXSkx-OU75IbMd8jNz9Om-P3yW_U7XVcjCXpFH8CfIsM_8zTAT1SsQ94CJnaHGgBaJieRlwSimhOII307AMtveLPBaICAedKj03BeqXD5nK1ngh-TIJr19c4xpeyBXBNl5nmVWZfEbB5mZe_YCY0W7wwAQjzZxiEerzDKK8u7QNyfvLu09tTNt3KwHwvuoG1QlipkuiElxbiTZWA365vnHbJ9hHCv5A0Dz7YiFDy3iXHO98nyGMgWfK8fUgOYA7xMaFOeem5TrKNstMpKhUgvLTatW0drO4q8nrLJPN9BN8wJWlRwowsNcBSU1hqVEXeIB93lAicXV6AOJlJnMy_xKkir1AKDKo3rJu30ykFmDACZZljSL_A7kktK3I4owS19PPmrRyZySxcmQaxeUStODS_2DVjTyx1y3G1QRqEEJSNAJpHo9jtPqmVXCuIcSuiZgI5--Z5S14uCmg44rhBdCie_I9VekpuNaMysaY_JAfDehOfQXA2uOdFD_8AseE9jw
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: ProQuest Central
  dbid: BENPR
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1baxQxFA66BfFFvDtaJYLgg4TOziXJPEkrLUVxEbHQt5Brd9XO1N1Zsf4v_5_nZLLbDoKPuzlhMnNu38nlCyGvpnbqKlcYKEsaw8ATc6Z1aVluGh5cAAwd4gbZGT8-qd6f1qdpwm2VtlVuYmIM1K6zOEe-VyCtCZ_KXLy9-MHw1ihcXU1XaNwkOwVUCvmE7Bwczj59vmLbg_Jnc1RG8r0VZDcIDJCnWF4B0mBylI4ia_-_sflachpvnLyWiY7ukjsJQtL9Qef3yA3f3ie3PqZF8gfkD_r40s-HrekUJwO-e4Yz9LTHzBTjBB5Gprp1NBI1pF8DPwlFViewSjr7QGMv_2uO7ECgwdhjHTlfab8-75ZJ4GcyYL28xGd8jUsBl3TR0rZr2Tckbl60i98wEtpqvDgBBNszeAi1eJdR253rh-Tk6PDLu2OWbmdgtuZVz0rOtZCBV9wKDbhTBtC7qQvTmKBrDzDQhSZ31mmPlPLWBJNXtg5Qz0DRZPPyEZnAGPwTQo20wuZNEKUXVRO8lA5gpm5MWU6dbqqMvNkoSV0MJBwqFi-Sq0GlClSqokqVzMgB6nEriQTa8Y9ueaaSP6oyTIW1Unhv6sohoSqCR-sswDvnuc3Ia7QChW4O383qdFoBBoyEWWofyjCIf6IRGdkdSYJ72nHzxo5UCg8rdWXMGXm5bcaeuOWt9d0aZZBKUBQcZB4PZrd9pVLkjQSsmxE5MsjRO49b2sU8kocjnxugRP70_-N6Rm4Xg5uwot4lk3659s8BfvXmRfKxvzEGNd8
  priority: 102
  providerName: ProQuest
– databaseName: Scholars Portal Journals: Open Access
  dbid: M48
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9QwELZKkRAXxJstBRkJiQMyZBPHdg4IFURVgeiJlXqz_Oxuab003UVd_hf_jxknuzSi4ph4rDieGc83if0NIS_Hbuy5Ly2kJY1l4IkFM6ZyrLCNiD4Cho55g-yhOJjwz0f10RZZlzvqJ_Di2tQO60lN2tM3l-er9-Dw77LDK_H2AmIWuDtEH1ZwwA9M3SA3Sw6ZOm7l4-ov9x4kQ-uDM9f2GwSnzOH_70p9JVQNt1FeiUv7d8mdHlDSvc4C7pGtkO6TW1_7X-YPyG_0-DZMu43qFD8NnAaG3-vpAuNUXjXwaDI1ydNM29BfdWwlFDmeYK7o4Reae4XLKXIFgT5zj2VmgKWL5dm87QV-9uZs2hU-4yT_GFjRWaJpnth3pHGepdkvGAlNBssogGA6hodQh5WN0vzMPCST_U_fPh6wvlYDc7XgC1YJYaSKggsnDaBQFcEKbF3axkZTBwCFPjaFd94EJJh3NtqCuzpCdgMplCuqR2QbxhCeEGqVk65ooqyC5E0MSnkAnaaxVTX2puEj8nqtJP2jo-TQOZVRQncq1aBSnVWq1Yh8QD1uJJFOO9-Yt8e6905dxbF0TskQbM090qsilHTeAdjzQbgReYVWoNEMYd6c6c8uwICRPkvvQVIGq6Fs5IjsDiTBWd2weW1Hem3rukTGHjFWBTS_2DRjT9wAl8J8iTJILChLATKPO7PbvFIli0YB8h0RNTDIwTsPW9JsmqnEkd0NMKPY-f-4npLbZecmrKx3yfaiXYZnAMYW9nn2sD_Kqjet
  priority: 102
  providerName: Scholars Portal
Title Comprehensive single-cell transcriptomic and proteomic analysis reveals NK cell exhaustion and unique tumor cell evolutionary trajectory in non-keratinizing nasopharyngeal carcinoma
URI https://www.ncbi.nlm.nih.gov/pubmed/37098551
https://www.proquest.com/docview/2815661807
https://search.proquest.com/docview/2806457267
https://pubmed.ncbi.nlm.nih.gov/PMC10127506
https://doaj.org/article/3f17cc87eeb54d74840155cdc159de6c
Volume 21
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LaxsxEBZJCqWX0nedpkaFQg9l4_U-JO0xDgmhxSaEBkwvQs_YbSwHxw5N_1f_X2e0uyZLb70s7GrEaj0zmm_k0SdCPg7N0BY205CWVDoBT0wTpXKTpLpi3nrA0D4WyE7Y2WXxZVpOdwhr98LEon2j54fhenEY5rNYW3mzMIO2TmxwPj5GTiqIdGywS3bBQtscvWXYg5Sn3R4j2OAWIhpMBhCbkrQAdJGITgiKTP3_zscPAlK3WPJB9Dl9Rp42sJEe1cN7TnZceEEej5s_xl-SP-jXKzery9EpLgBcuwRX5ekao1GcG3ADMlXB0kjO0NzVnCQUmZzAEunkK4293K8ZMgKB1mKPTeR5pevNYrlqBO4ao1Wre3zHj7j8f0_ngYZlSH4iWfM8zH_DSGhQeFgCCIYreAk1eH5RWC7UK3J5evLt-CxpTmRITMmKdZIzprjwrGCGK8CawoOudZnpSntVOoB-1lepNVY5pJE32uu0MKWHHAYSJZPmr8kejMG9JVQLw01aeZ47XlTeCWEBWqpK5_nQqqrokc-tkuRNTbwhY8IimKxVKkGlMqpUih4ZoR63kkiaHR8sV1eyMR2Z-yE3RnDndFlYJFFFwGisAUhnHTM98gmtQKJrw-9mVLNDAQaMJFnyCFIvmPN4xXvkoCMJLmm6za0dyWZKuJUZ8vKwoUih-cO2GXtimVtwyw3KIH0gzxjIvKnNbvtJOU8rAfi2R0THIDvf3G0B_4mE4a2_7P9_13fkSVa7UJKVB2Rvvdq49wDH1roPPjjlffJodDI5v-jHRQ24jgsB14vR9370zr-kckFv
link.rule.ids 230,315,730,783,787,867,888,2109,12068,21400,24330,27936,27937,31731,31732,33756,33757,43322,43817,53804,53806
linkProvider National Library of Medicine
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9QwELagSMAF8SyBAkZC4oCsZvOwnRMqiKrQdk-ttDfLz-4CTco-EOV_8f-YcbzbRkgcdz1WnMzbHn9DyJuRHbnKFQbSksYw0MScaV1alpuGBxcghg6xQHbMD06rL5N6kjbcFqmscm0To6F2ncU98t0CYU34SObi_cUPhl2j8HQ1tdC4SW4hDhd2MBCTq4SrguRnfVFG8t0F-DYwC-ClWF5BnMHkwBlFzP5_LfM11zQsm7zmh_bvk3spgKR7PccfkBu-fUhuH6cj8kfkD2r43E_7wnSKWwHfPcP9ebpEvxStBF5Fprp1NMI0pF89OglFTCeQSTo-pHGW_zVFbCDgX5yxioivdLk67-aJ4GcSXz2_xGd8jQcBl3TW0rZr2TeEbZ61s9-wEtpqbJsAhO0ZPIRa7GTUduf6MTnd_3Ty8YCl3gzM1rxaspJzLWTgFbdCQ9QpA3Dd1IVpTNC1hyDQhSZ31mmPgPLWBJNXtg6QzUDKZPPyCdmCNfinhBpphc2bIEovqiZ4KR0EmboxZTlyuqky8m7NJHXRQ3ComLpIrnqWKmCpiixVMiMfkI8bSoTPjn908zOVtFGVYSSslcJ7U1cO4VQxdLTOQnDnPLcZeYtSoFDJ4btZne4qwIIRLkvtQRIG1k80IiM7A0pQTjscXsuRSsZhoa5EOSOvN8M4EwveWt-tkAaBBEXBgWa7F7vNK5UibyREuhmRA4EcvPNwpJ1NI3Q4orlBjMif_X9dr8idg5PjI3X0eXz4nNwtepVhRb1DtpbzlX8BgdjSvIza9hfMmjdq
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9NAEF5BkSoulDcpBRYJiQNy4vixXh9LISqURj1QqRKH1T6b0GYTJQ6i_V_8P2bWdlTDrcdkZ-Xd5JuZb-zZz4S8G-qhyUyioCwpVQSeGEdSpjqKVcmcccChXWiQHbPD0-zrWX7WdFWumrZKr9W07y9nfT-dhN7KxUwP2j6xwcnxAWpSQaZjg4Vxg7vkHjhtzNpKvdXZg8KnPSTD2WAFeQ1CAmSoKM6AY0S8k4iCXv__UflGWuq2TN7IQaMd8qNdfd16ctFfV6qvr_8Rdrzd9h6SBw01pfu1zSNyx_rHZPu4efj-hPzB2LG0k7rlneJNhksb4Z1_WmHGC_EHDzlT6Q0NAhDNp1r3hKJaFKCdjo9omGV_T1B1CJARZqyDliyt1rP5sjH41TiGXF7hNX6GRwxXdOqpn_voAgWhp356DSuhXuILGcDQn8NFqMZ3JPn5TD4lp6PP3w8Oo-atD5HOWVZFKWOy4I5lTBcS-Cx3gCeVJ6pUTuYW6KVxZWy0kRal6rVyKs507qBOgmJMx-kzsgVrsC8IVVwXOi5dkdoiK53l3AB9laVK06GRZdYjH1oIiEUt7iFCUcSZqAEjADAiAEbwHvmIKNlYojB3-GK-PBfN_ydSNyy05oW1Ks8MCrUiKdVGA200lukeeY8YExg-4HfTsjkFAQtGIS6xD-UdxNWiLHpkr2MJbq-7wy1KRRN2ViJB7R825DEMv90M40xspfN2vkYblCgsEgY2z2tQb7aUFnHJgUP3CO_AvbPn7giAOIiSt6Ddvf3UN2T75NNIfPsyPnpJ7ie1r0ZJvke2quXavgL2V6nXwc3_Ai1EYK0
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Comprehensive+single-cell+transcriptomic+and+proteomic+analysis+reveals+NK+cell+exhaustion+and+unique+tumor+cell+evolutionary+trajectory+in+non-keratinizing+nasopharyngeal+carcinoma&rft.jtitle=Journal+of+translational+medicine&rft.au=Chen%2C+Cuimin&rft.au=Wang%2C+Chun&rft.au=Pang%2C+Ruifang&rft.au=Liu%2C+Huanyu&rft.date=2023-04-25&rft.pub=BioMed+Central&rft.eissn=1479-5876&rft.volume=21&rft.spage=1&rft_id=info:doi/10.1186%2Fs12967-023-04112-8
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1479-5876&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1479-5876&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1479-5876&client=summon